Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
---|
09/30/2004 | US20040191563 Novel aromatic compounds and organic electroluminescent devices made by using the same |
09/29/2004 | EP1461323A2 Compounds for the treatment of metabolic disorders |
09/29/2004 | EP1461306A1 Quaternary ammonium compounds and their use as antimuscarinic agents |
09/29/2004 | EP1460994A2 Compounds for a controlled release of active molecules |
09/29/2004 | EP1100483B1 Glucocorticoid-selective anti-inflammatory agents |
09/29/2004 | CN1532194A Process for preparing aryl ether |
09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
09/28/2004 | US6797344 Polyimide resin according wherein the diamine comprises for example1-(4-(2,4-diaminophenoxy)phenoxy)dodecane |
09/23/2004 | WO2004080934A2 Process for preparation of phenethylamine derivatives |
09/23/2004 | WO2004072088A3 Phosphine compound, intermediate, palladium-complex, and use thereof |
09/23/2004 | US20040186080 Beta 2-adrenergic receptor agonists |
09/23/2004 | US20040186061 Novel derivatives of 3,3-diphenylpropylamines |
09/23/2004 | CA2517164A1 Process for preparation of phenethylamine derivatives |
09/22/2004 | EP1458743A1 Tetrahydrobenzfluorene derivatives |
09/22/2004 | EP1458370A1 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine |
09/22/2004 | EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
09/22/2004 | CN1531520A Self-reducing anthraquinone compounds |
09/22/2004 | CN1530359A Tertiary alkanolamine containing tensioactive alkyl group |
09/21/2004 | US6794543 Method for producing arylpoly(oxalkyl)-benzyldimethyl-ammonium derivatives |
09/21/2004 | US6794530 Process for making γ-alkoxyamines |
09/21/2004 | US6794515 Synthesis of 2-alkylcysteine via substituted thiazoline amide |
09/21/2004 | US6794415 Biphenyl compounds and their use as oestrogenic agents |
09/21/2004 | CA2211133C Process for preparing 2-trifluoromethoxy-aniline |
09/16/2004 | WO2003096989A3 Anti tubercular drug: compositions and methods |
09/16/2004 | US20040181093 Catalytic hydrogen of olefin using cobalt or nickel catalyst for preparation of phenethylamine |
09/16/2004 | US20040181077 Tertiary alkanolamines containing surface active alkyl groups |
09/16/2004 | US20040180979 Tertiary alkanolamines containing surface active alkyl groups |
09/16/2004 | US20040180970 Gemini glycidyl ether adducts of polyhydroxyalkyl alkylenediamines |
09/16/2004 | US20040180966 Enantiomers of N-desmethyl venlafaxine |
09/16/2004 | US20040180952 Derivatives of (-)- and (+)-venlafaxine and methods of preparing and using the same |
09/16/2004 | US20040177879 solar cells; organic electrically conducting agent exhibits a melting temperature TM which is lower than the operation temperature of the photoelectric conversion device |
09/15/2004 | EP1457570A1 Process for preparation of 2-aminotetralin derivatives and intermediates thereof |
09/15/2004 | EP1457481A1 Gemini glycidyl ether adducts of polyhydroxyalkyl alkylenediamines |
09/15/2004 | EP1457480A1 Tertiary alkanolamines containing surface active alkyl groups |
09/15/2004 | EP1456253A1 Bidentate ligand based catalyst for the polymerization of olefins |
09/15/2004 | EP1213279B1 Venlafaxine production process |
09/15/2004 | EP0947498B1 Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for preparing the same |
09/15/2004 | EP0775689B9 Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic |
09/15/2004 | CN1529691A N-Benzyl-M-Phenylenedimine derivatives and dyes containing said compounds |
09/15/2004 | CN1166623C 2-phenoxyaniline derivatives |
09/14/2004 | US6790975 Organic electroluminescence; condensation from a corresponding aminobenzaldehyde and a phosphonic ester or phosphonium salt; yellow to red light |
09/14/2004 | US6790974 Bis(aminostyryl) naphthalene compound, synthesis intermediate thereof, and process for production thereof |
09/14/2004 | US6790865 2-methylpropionic acid derivatives and pharmaceutical compositions comprising the same |
09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
09/10/2004 | WO2004037226B1 Pharmaceutical compositions containing venlafaxine |
09/10/2004 | WO2004028451A3 β-HYDROXYPHENYLALKYLAMINES AND THEIR USE FOR TREATING GLAUCOMA |
09/10/2004 | WO2004017920B1 Novel biphenyl and biphenyl-like cannabinoids |
09/10/2004 | WO2004009034A3 Thiomolybdate analogues and uses thereof |
09/09/2004 | US20040176642 by reducing a nitrostilbene derivative, developing a selective reducing method for nitro groups which yields less amount of waste matters and has high selectivity consequently; for anticancer drugs |
09/09/2004 | US20040176335 Novel cocrystallization |
09/09/2004 | US20040175314 may be incorporated into packaging materials , for example, food and beverage packaging to scavenge unwanted oxygen; to reveal leaks in packages or to indicate package damage caused by handling or tampering |
09/08/2004 | EP1453816A2 Phenoxy amine compounds and compositions for delivering active agents |
09/08/2004 | EP1453796A2 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same |
09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/08/2004 | EP1453788A1 Substituted hydroxyethylamines |
09/08/2004 | CN1526689A Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate |
09/08/2004 | CN1165590C Polymerizable propenoic acid compositions and use thereof |
09/08/2004 | CN1165512C Recovery of amines from emulsions |
09/07/2004 | US6787570 Administering an aromatic or heteroaromatic substituted tertiaryamine compound to treat atherosclerosis, dyslipidemia, and other coronary artery diseases |
09/02/2004 | WO2004073709A1 Antimicrobial agents |
09/02/2004 | US20040171881 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
09/02/2004 | US20040171833 Ligands for metals and improved metal-catalyzed processes based thereon |
09/02/2004 | US20040171670 Neurological diseases and disorders; such as 3-fluoro-10,11-dihydro-5-(2-aminoethyl)-5H-dibenzo[a,d]cycloheptene |
09/02/2004 | US20040171618 Compounds as PDE IV and TNF-inhibitors |
09/02/2004 | US20040171572 Complex cationic lipids having quaternary nitrogens therein |
09/02/2004 | US20040169161 Using a quaternary ammonium compound containing ether groups |
09/01/2004 | EP1451146A1 Venlafaxine hydrochloride monohydrate and methods for the preparation thereof |
09/01/2004 | EP1451145A1 Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof |
09/01/2004 | EP1228024B1 Novel hydronaphthalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
09/01/2004 | EP1072583B1 2-methylpropionic acid derivatives and medicinal compositions containing the same |
09/01/2004 | CN1525966A New compounds, which are potent inhibitors of Na<+>/Ca<2+> exchange mechanism and are useful in the treatment of arrhythmias |
09/01/2004 | CN1164563C 1,3,5-tri (4-amino phenoxy) benzene and preparation method thereof |
09/01/2004 | CN1164562C Process for preparing 4,4-diaminodiphenyl ether |
08/31/2004 | US6784319 Synthesis of (±)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols |
08/31/2004 | US6784314 Process for producing amine derivatives |
08/31/2004 | US6784210 Decyclization of oxabenzonorbornadienes or azabicyclic compounds in the presence of catalysts to form naphthalenes, such as 2-methoxy-1,2-dihydronaphthalen-1-ol, used as analgesics, anticarcinogens or viricides; catalysis |
08/31/2004 | US6784175 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments |
08/26/2004 | WO2004072088A2 Phosphine compound, intermediate, palladium-complex, and use thereof |
08/26/2004 | WO2004072015A1 Quaternary ammonium salts |
08/26/2004 | WO2004071426A2 Compounds for the treatment of viral infection |
08/26/2004 | WO2004071401A2 Hydroxamic acid derivatives as histone deacetylase inhibitors (hdca) |
08/26/2004 | WO2004071388A2 Medicinal compounds |
08/26/2004 | WO2003048082A3 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
08/26/2004 | US20040164278 Corrosion and gas hydrate inhibitors having improved water solubility and increased biodegradability |
08/26/2004 | CA2515544A1 Compounds for the treatment of viral infection |
08/25/2004 | EP1449940A1 Corrosion and gas hydrates inhibitors with improved water solubilty and biodegradabilty |
08/25/2004 | EP1252327B1 Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives |
08/25/2004 | CN1163469C Aniline derivative and producing process thereof |
08/24/2004 | US6780999 Primary intermediates for oxidative coloration of hair |
08/24/2004 | US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same |
08/24/2004 | US6780891 Modulate opiate receptors; central nervous system disorders |
08/24/2004 | US6780863 Treat inflammatory and/or allergic conditions |
08/24/2004 | US6780821 Substituted phenyl uracils |
08/19/2004 | WO2004047751A3 Calcilytic compounds |
08/19/2004 | US20040162433 Lipoxin A4 analogs |
08/19/2004 | US20040162432 Substituted octahydrophenanthrene compounds and use thereof as NMDA antagonists |
08/19/2004 | US20040162256 Method for producing sterile polynucleotide based medicaments |
08/18/2004 | EP1446379A1 Aryl aniline beta-2 adrenergic receptor agonists |
08/18/2004 | EP1359887A4 Primary intermediates for oxidative coloration of hair |
08/18/2004 | EP1194037B1 Agrochemical compositions and surfactant compounds |